Our exploration of the link between CPZ expression and the sensitivity to numerous anti-tumor drugs revealed that high CPZ expression is associated with reduced sensitivity to some first-line chemotherapeutic drugs, such as oxaliplatin, cisplatin, and docetaxel. Here, CPZ is linked to neoplasm.